Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene

Evans, D; Bode, A; von der Lippe, G; Beil, FU; Mann, WA

doi:10.1186/2047-783X-16-2-79

Table 1 Clinical characteristics of patients with bulbar plaque present or absent.

From: Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the Apolipoprotein A5 gene

A) Plaque present
Pat Num	AGE years	SEX M/F	IMT ACC mm	IMT -bulb mm	Lp(a) mg/dl	Smoker s/ex/n	D M 2	HT	KHK	AVK	CVI	Chol	Trig	HDL
101	37	M	0.75	0.90	105	N	-	-	-	-	-	481	588	69
76	41	M	0.93	1.83	6	Y	-	+	-	+	-	265	674	54
90	44	M	0.75	0.88	54	Y	-	-	+	-	-	426	418	41
36	44	M	0.67	1.45	2	Y	-	-	-	-	-	418	983	53
35	45	M	0.70	1.50	< 2	EX	-	+	+	+	-	268	558	46
44	45	M	0.83	1.48	3	Y	-	-	-	-	-	439	476	36
28	47	M	0.85		15	Y	-	-	-	-	-	316	634	53
86	50	F	0.80	0.95	2	Y	-	-	-	-	-	484	636	71
63	50	M	0.78	1.10	< 2	N	-	-	-	-	-	240	364	37
4	52	F	0.95	1.75	11	N	-	+	-	-	-	651	433	44
87	52	M	0.83	1.03	< 2	N	-	+	-	-	-	182	418	41
20	53	F	1.08	1.90	4	Y	-	-	-	-	-	503	360	47
45	53	M	0.95	1.00	8	Y	-	-	-	+	-	273	315	37
71	55	M	1.10	1.60	3	EX	-	+	-	-	+	441	716	68
27	55	M	0.95	1.45	< 2	N	+	+	+	-	-	317	560	40
48	55	F	1.25	1.83	< 2	N	-	-	-	-	-	428	460	42
37	57	F	0.90	1.43	11	Y	-	-	-	-	-	435	388	46
52	59	M	1.08	1.63	< 2	Y	-	-	-	-	+	137	69	57
38	48	M	0.83	1.23	15	Y	-	-	-	-	-	292	428	39
93	61	F			32	Y	-	+	-	-	-	341	777	33
6	62	F	0.70	1.05	22	N	-	-	-	-	-	336	411	50
16	62	M	0.80	1.13	< 2	N	-	-	-	-	-	416	405	49
89	65	M	0.83	1.28	9		-	-	+	-	-	393	555	44
3	69	M	0.92	2.15	10	EX	-	+		-	-	331	548	41
91	76	F	0.90	1.55	7	N	+
Mean	53.5		0.88	1.40	13							367	507	47
n	25	17/8				12/3/9	2	8	4	3	2
B) Plaque absent
Pat Num	AGE years	SEX m/f	IMT ACC mm	IMT- Bulbus mm	Lp(a)	Smoker s/ex/n	DM2	HT	KHK	AVK	CVI	Chol	Trig	HDL
46	28	M	0.80	1.58	10	Y	-	-	-	-	-	246	143	41
100	30	M	0.73	1.05	19	Y	-	-	-	-	-	694	1118	44
40	31	M	0.77	0.80	4	Y	-	-	-	-	-	201	261	29
72	32	M	0.67	0.85	3		-	-	-	-	-	446	729	51
33	34	M	0.70	0.88	7	Y	-	-	-	-	-
62	36	M	0.60	0.67	10	N	-	-	-	-	-	202	177	65
60	37	M	0.67	1.05	3	Y	-	-	-	-	-	225	293	37
65	38	F	0.72	0.93	< 2	EX	-	+	-	-	-	377	949	40
97	38	M	0.60	0.83	2	EX	-	-	-	-	-	408	402	69
21	39	M	0.70	0.98	3	Y	-	-	-	-	-	143	266	32
73	39	F	0.75	0.88	10	EX	-	-	-	-	-	579	519	55
102	40	M	0.78	0.93	19	N	-	-	-	-	-	196	165	52
5	41	F	0.65	0.65	27	N	+	-	-	-	-	598	939	57
14	41	F	0.73	0.98	9	EX	-	-	-	-	-	255	120	63
50	42	M	0.68	1.05	15	EX	-	+	+	-	-	251	407	29
8	42	M	0.65	0.65	< 2	Y	-	-	-	-	-	154	258	41
95	42	F	0.90	1.55	11	EX	-	+	+	-	-	286	473	35
61	43	M	0.63	0.92	4	EX	-	-	-	-	-	360	678	57
12	43	M	0.80	0.98	7	Y	-	-	-	-	-	149	92	56
64	44	M	0.80	0.73	17	Y	+	+	-	-	-	444	932	49
47	47	M	0.78	0.95	4	N	-	-	-	-	-	483	641	35
85	47	M	0.73	0.78	< 2	EX	-	-	-	-	-	380	727	50
94	48	M	1.05	1.03	< 2	N	-	+	-	-	-	285	313	54
11	50	M	0.77	0.93	14	Y	-	-	-	-	-	343	513	40
1	50	F	0.60	0.85	8	Y	-	-	-	-	-	532	311	57
53	51	M	0.92	1.00	49	EX	-	-	+	-	-	252	198	41
25	51	M	0.70	0.98	< 2		-	+	-	-	-	414	682	38
98	56	M		0.70	< 2	Y	+	-	-	-	-	399	762	48
34	56	F	0.77	1.40	8	EX	+	-	+	-	-	665	1640	78
59	58	M	0.85	1.30	< 2	N	-	-	-	-	-	204	282	62
31	60	F	0.80	1.05	52	N	-	-	-	-	-	397	283	70
23	61	M	0.73	1.03	56	EX	+	+	-	-	-	442	709	50
74	63	F	0.80	1.23	15	EX	-	-	-	-	-	211	323	42
70	70	F	0.83	1.43	13	N	-	-	-	-	-	473	609	65
66	74	M	0.85	1.08	5	N	+	-	+	-	+	276	752	56
Mean	46		0.75	0.99	12							354	558	50
n	35	25/10				12/12/10	6	7	5	0	1

Patients are listed in order of increasing age. + = presence of DM2 or hypertension (HT); IMT in mm; Lp(a) in mg/dl

Back to article page

ISSN: 2047-783X

Contact us

Submission enquiries: jacinth.kennady@springernature.com
General enquiries: info@biomedcentral.com

European Journal of Medical Research

Contact us